vs
Side-by-side financial comparison of P10, Inc. (PX) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
P10, Inc. is the larger business by last-quarter revenue ($81.0M vs $76.2M, roughly 1.1× VIEMED HEALTHCARE, INC.). P10, Inc. runs the higher net margin — 11.7% vs 7.4%, a 4.3% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -4.7%). P10, Inc. produced more free cash flow last quarter ($18.1M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 10.7%).
P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
PX vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $81.0M | $76.2M |
| Net Profit | $9.5M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 31.9% | 11.0% |
| Net Margin | 11.7% | 7.4% |
| Revenue YoY | -4.7% | 25.5% |
| Net Profit YoY | 79.0% | 30.7% |
| EPS (diluted) | $0.08 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $81.0M | $76.2M | ||
| Q3 25 | $75.9M | $71.9M | ||
| Q2 25 | $72.7M | $63.1M | ||
| Q1 25 | $67.7M | $59.1M | ||
| Q4 24 | $85.0M | $60.7M | ||
| Q3 24 | $74.2M | $58.0M | ||
| Q2 24 | $71.1M | $55.0M | ||
| Q1 24 | $66.1M | $50.6M |
| Q4 25 | $9.5M | $5.6M | ||
| Q3 25 | $2.1M | $3.5M | ||
| Q2 25 | $3.4M | $3.2M | ||
| Q1 25 | $4.5M | $2.6M | ||
| Q4 24 | $5.3M | $4.3M | ||
| Q3 24 | $1.4M | $3.9M | ||
| Q2 24 | $7.0M | $1.5M | ||
| Q1 24 | $5.0M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 31.9% | 11.0% | ||
| Q3 25 | 14.1% | 7.8% | ||
| Q2 25 | 24.4% | 8.1% | ||
| Q1 25 | 16.6% | 6.5% | ||
| Q4 24 | 26.9% | 10.6% | ||
| Q3 24 | 11.9% | 9.7% | ||
| Q2 24 | 23.7% | 6.6% | ||
| Q1 24 | 18.3% | 4.4% |
| Q4 25 | 11.7% | 7.4% | ||
| Q3 25 | 2.8% | 4.9% | ||
| Q2 25 | 4.7% | 5.0% | ||
| Q1 25 | 6.7% | 4.4% | ||
| Q4 24 | 6.2% | 7.1% | ||
| Q3 24 | 1.9% | 6.7% | ||
| Q2 24 | 9.8% | 2.7% | ||
| Q1 24 | 7.6% | 3.2% |
| Q4 25 | $0.08 | $0.14 | ||
| Q3 25 | $0.02 | $0.09 | ||
| Q2 25 | $0.03 | $0.08 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $0.05 | $0.10 | ||
| Q3 24 | $0.01 | $0.10 | ||
| Q2 24 | $0.06 | $0.04 | ||
| Q1 24 | $0.04 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.2M | $13.5M |
| Total DebtLower is stronger | $373.2M | — |
| Stockholders' EquityBook value | $403.5M | $141.5M |
| Total Assets | $928.3M | $199.2M |
| Debt / EquityLower = less leverage | 0.93× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $13.5M | ||
| Q3 25 | $40.0M | $11.1M | ||
| Q2 25 | $33.4M | $20.0M | ||
| Q1 25 | $74.4M | $10.2M | ||
| Q4 24 | $67.5M | $17.5M | ||
| Q3 24 | $61.5M | $11.3M | ||
| Q2 24 | $31.2M | $8.8M | ||
| Q1 24 | $29.0M | $7.3M |
| Q4 25 | $373.2M | — | ||
| Q3 25 | $393.4M | — | ||
| Q2 25 | $373.0M | — | ||
| Q1 25 | $357.2M | — | ||
| Q4 24 | $319.8M | — | ||
| Q3 24 | $319.4M | — | ||
| Q2 24 | $300.6M | — | ||
| Q1 24 | $314.0M | — |
| Q4 25 | $403.5M | $141.5M | ||
| Q3 25 | $396.8M | $133.6M | ||
| Q2 25 | $388.9M | $139.7M | ||
| Q1 25 | $374.3M | $134.8M | ||
| Q4 24 | $386.9M | $131.4M | ||
| Q3 24 | $394.1M | $125.0M | ||
| Q2 24 | $396.9M | $119.4M | ||
| Q1 24 | $400.1M | $116.3M |
| Q4 25 | $928.3M | $199.2M | ||
| Q3 25 | $936.0M | $202.4M | ||
| Q2 25 | $932.2M | $184.6M | ||
| Q1 25 | $877.4M | $178.1M | ||
| Q4 24 | $869.3M | $177.1M | ||
| Q3 24 | $857.0M | $169.5M | ||
| Q2 24 | $823.2M | $163.9M | ||
| Q1 24 | $832.8M | $154.9M |
| Q4 25 | 0.93× | — | ||
| Q3 25 | 0.99× | — | ||
| Q2 25 | 0.96× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 0.83× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.0M | $18.4M |
| Free Cash FlowOCF − Capex | $18.1M | $9.7M |
| FCF MarginFCF / Revenue | 22.3% | 12.7% |
| Capex IntensityCapex / Revenue | 6.0% | 11.5% |
| Cash ConversionOCF / Net Profit | 2.43× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $14.1M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.0M | $18.4M | ||
| Q3 25 | $-8.6M | $18.4M | ||
| Q2 25 | $13.4M | $12.3M | ||
| Q1 25 | $-4.7M | $2.9M | ||
| Q4 24 | $101.0M | $15.0M | ||
| Q3 24 | $27.5M | $12.7M | ||
| Q2 24 | $34.8M | $10.2M | ||
| Q1 24 | $11.0M | $1.2M |
| Q4 25 | $18.1M | $9.7M | ||
| Q3 25 | $-9.5M | $10.7M | ||
| Q2 25 | $11.6M | $4.1M | ||
| Q1 25 | $-6.0M | $-12.6M | ||
| Q4 24 | $96.6M | $3.2M | ||
| Q3 24 | $25.2M | $1.7M | ||
| Q2 24 | $33.9M | $1.2M | ||
| Q1 24 | $10.7M | $-4.8M |
| Q4 25 | 22.3% | 12.7% | ||
| Q3 25 | -12.6% | 14.9% | ||
| Q2 25 | 15.9% | 6.5% | ||
| Q1 25 | -8.9% | -21.4% | ||
| Q4 24 | 113.6% | 5.2% | ||
| Q3 24 | 34.0% | 3.0% | ||
| Q2 24 | 47.7% | 2.3% | ||
| Q1 24 | 16.2% | -9.5% |
| Q4 25 | 6.0% | 11.5% | ||
| Q3 25 | 1.2% | 10.6% | ||
| Q2 25 | 2.5% | 12.9% | ||
| Q1 25 | 1.9% | 26.2% | ||
| Q4 24 | 5.2% | 19.5% | ||
| Q3 24 | 3.0% | 19.0% | ||
| Q2 24 | 1.3% | 16.3% | ||
| Q1 24 | 0.4% | 11.9% |
| Q4 25 | 2.43× | 3.27× | ||
| Q3 25 | -4.01× | 5.23× | ||
| Q2 25 | 3.96× | 3.88× | ||
| Q1 25 | -1.05× | 1.09× | ||
| Q4 24 | 19.12× | 3.47× | ||
| Q3 24 | 19.54× | 3.29× | ||
| Q2 24 | 4.98× | 6.94× | ||
| Q1 24 | 2.18× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PX
| Management Fees | $78.1M | 96% |
| Advisory Fees | $1.8M | 2% |
VMD
Segment breakdown not available.
